Scientists at the University of Oxford have just received funding to create the world's first vaccine for ovarian cancer, a deadly disease that affects thousands of people each year. The vaccine, called OvarianVax,

If successful, the vaccine could protect women against ovarian cancer, which only around half of women survive long-term at the moment.

A laboratory hoping to develop a vaccine for ovarian cancer has been awarded funding. Scientists at the University of Oxford are creating OvarianVax, a vaccine which they hope will teach the immune system to recognise and attack the earliest stages of ovarian cancer.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news

The hope is the jab could be given to all women preventatively on the NHS to eliminate the disease, which is the sixth most common cancer in women.

The world’s first ovarian cancer vaccine has been awarded research funding in the United Kingdom, marking the first step toward a groundbreaking preventive measure that scientists say could eliminate the disease entirely.

A first-ever ovarian cancer vaccine – currently being developed by the University of Oxford hopes to wipe off the deadly cancer – which kills thousands of women across the world yearly. According to scientists – the jab could be given to all women preventatively to eliminate the disease,